PDE7A and cancer: Regarding the chronology of the treatment, our study showed that the pretreatment of EOC cells with the PDE7 inhibitor, followed by its combination with PTX was more efficient in controlling tumorigenesis, opening the discussion about the therapeutic scheme in cancer treatment.